ストックスクリーナーアプリを入手
0.8013
0.78%
-0.0063
アフターアワーズ：
.77
-0.0313
-3.91%
前日終値:
$0.8076
開ける：
$0.7426
24時間の取引高:
331.38K
Relative Volume:
2.48
時価総額：
$2.88M
収益：
-
当期純損益:
$-4.14M
株価収益率:
-0.1105
EPS:
-7.2511
ネットキャッシュフロー:
$-4.79M
1週間 パフォーマンス:
-8.95%
1か月 パフォーマンス:
+19.60%
6か月 パフォーマンス:
-34.85%
1年 パフォーマンス:
-47.97%
1日の値動き範囲:
$0.7426
$0.8396
1週間の範囲:
$0.7426
$0.968
52週間の値動き範囲:
$0.57
$4.25
Bone Biologics Corp Stock (BBLG) Company Profile
名前
Bone Biologics Corp
セクター
電話
(781) 552-4452
住所
2 BURLINGTON WOODS DRIVE,, BURLINGTON
BBLG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.8013 | 2.88M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Bone Biologics Corp (BBLG) 最新ニュース
Bone Biologics announces 1-for-6 reverse stock split By Investing.com - Investing.com South Africa
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split | BB - GuruFocus
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split - GuruFocus
Bone Biologics announces 1-for-6 reverse stock split - Investing.com India
Bone Biologics Finalizes 1-for-6 Reverse Split: Key Details for Nasdaq Biotech Investors - Stock Titan
Bone Biologics (NASDAQ:BBLG) Trading Down 2.4% – What’s Next? - Defense World
Bone Biologics shareholders approve key proposals By Investing.com - Investing.com Canada
Bone Biologics shareholders approve key proposals - Investing.com
Global and China Osteoporosis Drugs Market Detailed in New Research ReportAmgen, Eli Lilly - openPR.com
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - The Globe and Mail
Bone Biologics (OTC:BBLG) Shares Up 18.5% – Time to Buy? - Defense World
TETROUS®, INC. ANNOUNCES EXPANDED CLINICAL APPLICATIONS OF ENFIX® FOR ENTHESIS REPAIR - Longview News-Journal
(BBLGW) Proactive Strategies - news.stocktradersdaily.com
WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering - Barchart.com
Zacks Small Cap Forecasts Bone Biologics Q2 Earnings - Defense World
Bone Biologics Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Trend Tracker for (BBLGW) - news.stocktradersdaily.com
Orthobiologics Market Grows Strong with Expanding Use in Sports - openPR.com
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - IT News Online
Revolutionary BMP Super-Agonists: Darnatein's New Biologics Promise Breakthrough in Bone and Cartilage Repair - Stock Titan
Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe - Yahoo Finance
Bone Biologics (OTC:BBLG) Trading Down 0.4% – Should You Sell? - Defense World
BBLG stock touches 52-week low at $0.57 amid market challenges By Investing.com - Investing.com South Africa
BBLG stock touches 52-week low at $0.57 amid market challenges - Investing.com Australia
Orthobiologics Market Set to Witness Significant Growth - openPR.com
Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine - Equitypandit
When (BBLGW) Moves Investors should Listen - news.stocktradersdaily.com
BBLG stock touches 52-week low at $0.7 amid market challenges - Investing.com Canada
BBLG stock touches 52-week low at $0.7 amid market challenges By Investing.com - Investing.com South Africa
Bone Biologics (OTC:BBLG) Trading 1.9% Higher – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bone Biologics sets date for 2025 annual meeting - Investing.com
Top Trend In Orthobiologics Devices And Equipment Market 2025: Biodegradable Implants Transforming Orthobio... - WhaTech
Orthobiologics Market Future Business Opportunities - openPR.com
TETROUS®, INC. SIGNS NEW DISTRIBUTION AGREEMENT IN NEW ZEALAND TO EXPAND PRESENCE IN THE ASIA-PACIFIC MARKET AND ADDS DR. CRAIG BALL TO IT'S SURGEON ADVISORY BOARD - PR Newswire
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors - The Malaysian Reserve
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading 1.2% Higher – Here’s Why - Defense World
MTF Biologics Collaborates with Kolosis BIO to Boost DBX Brand - World Business Outlook
MTF Biologics Expands Partnership with Kolosis BIO to Strengthen DBX Brand - StreetInsider.com
TETROUS®, INC. SUCCESSFULLY CLOSES FINANCING ROUND, SECURING ADDITIONAL CAPITAL FOR FUTURE GROWTH - PR Newswire
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Down 15.9% in February - Defense World
BBLG stock touches 52-week low at $0.8 amid market challenges - Investing.com
Orthobiologics Market Generated Opportunities, Future Scope - openPR
Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA - Yahoo Finance
BBLG: Funding Looks Good as Trials Continue - Research Tree
Bone Biologics Corp SEC 10-K Report - TradingView
Orthobiologics Market : Comprehensive Overview, Trends, and Future Outlook 2025-2035 - PharmiWeb.com
Key Bone Void Fillers Market Trend 2025-2034: Advancements In Bone Healing Through Carbohydrate Polymer Tec... - WhaTech
Bone Biologics (BBLG) Expected to Release Quarterly Earnings on Wednesday - Defense World
Bone Biologics Corp (BBLG) 財務データ
収益
当期純利益
現金流量
EPS
0.56%
1.70%
大文字化:
|
ボリューム (24 時間):